VERENIGING VOOR CHRISTELIJK HOGER ONDERWIJS, WETENSCHAPPELIJK ONDERZOEK EN PATIENTENZORG
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 29, 2016 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 82 Total Citation Count
- Sep 22, 1998 Earliest Filing
- 29 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2014/0256,590 METHOD OF ANALYSING A BLOOD SAMPLE OF A SUBJECT FOR THE PRESENCE OF A FOETAL DISEASE OR CONDITION MARKERAug 08, 12Sep 11, 14[C12Q, G01N]
2011/0007,144 METHOD OF EVALUATING A RECONSTRUCTED SURFACE, CORNEAL TOPOGRAPHER AND CALIBRATION METHOD FOR A CORNEAL TOPOGRAPHERNov 02, 07Jan 13, 11[H04N, G06K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8629258 Plant nucleic acids associated with cellular pH and uses thereofMay 28, 07Jan 14, 14[C12N, A01H]
8318149 Replication competent viruses capable of silencing virus inhibitory factor expressionOct 09, 06Nov 27, 12[A61K, C12N]
7916306 Optical device comprising a cantilever and method of fabrication and use thereofNov 28, 05Mar 29, 11[G01B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0218,641 METHOD FOR PROGNOSTICATING THE CLINICAL RESPONSE OF A PATIENT TO B-LYMPHOCYTE INHIBITING OR DEPLETING THERAPY IN INTERFERON-DRIVEN DISEASES SUCH AS SLEAbandonedFeb 27, 15Aug 06, 15[C12Q, C07K]
2014/0213,788 PROCESS FOR THE PREPARATION OF ALPHA-ACYLOXY BETA-FORMAMIDO AMIDESAbandonedMar 28, 14Jul 31, 14[C07D, C07C]
2014/0094,378 MEANS AND METHODS FOR CLASSIFYING SAMPLES OF MULTIPLE SCLEROSIS PATIENTSAbandonedAug 26, 13Apr 03, 14[C12Q, G01N]
2014/0030,261 METHOD FOR PROGNOSTICATING THE CLINICAL RESPONSE OF A PATIENT TO B-LYMPHOCYTE INHIBITING OR DEPLETING THERAPY IN INTERFERON-DRIVEN DISEASES SUCH AS SLEAbandonedNov 30, 11Jan 30, 14[C12Q]
8530486 Quinazolines and related heterocyclic compounds, and their therapeutic useExpiredJan 02, 09Sep 10, 13[A61K]
2013/0217,055 METHOD FOR PREDICTING TYROSINE KINASE INHIBITOR (TKI) RESISTANCE IN PATIENTS SUFFERING FROM CHRONIC MYELOGENOUS LEUKEMIA (CML)AbandonedOct 17, 11Aug 22, 13[C12Q]
2012/0251,557 GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOFAbandonedApr 10, 12Oct 04, 12[A61K, G01N, A61P, C07K]
2012/0093,734 PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL ADENOCARCINOMAAbandonedMar 31, 10Apr 19, 12[A61K, G01N, C07K]
2012/0035,076 IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMERAbandonedApr 26, 10Feb 09, 12[C12Q, C40B]
2011/0236,396 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A COLORECTAL ADENOCARCINOMAAbandonedSep 10, 09Sep 29, 11[A61K, C07H, C12Q, A61P, C40B, C07K]
2011/0206,639 REPLICATION COMPETENT VIRUSES CAPABLE OF SILENCING VIRUS INHIBITORY FACTOR EXPRESSIONAbandonedSep 03, 10Aug 25, 11[C07H, A61K, C12N, A61P]
2011/0189,234 ADENOVIRUS PARTICLES HAVING A CHIMERIC ADENOVIRUS SPIKE PROTEIN, USE THEREOF AND METHODS FOR PRODUCING SUCH PARTICLESAbandonedFeb 13, 07Aug 04, 11[A61K, C07H, C12N, A61P]
2011/0148,861 PET DATA PROCESSING SYSTEM, AN ARRANGEMENT, A METHOD AND A COMPUTER PROGRAM PRODUCT FOR DETERMINING A DISTRIBUTION OF A TRACER UPTAKEAbandonedApr 08, 08Jun 23, 11[G06T, G06K]
2011/0046,006 MEANS AND METHODS FOR TYPING A CELL ISOLATE OF AN INDIVIDUAL SUFFERING FROM A PSYCHIATRIC DISORDER OR AT RISK OF SUFFERING THERE FROMAbandonedDec 19, 08Feb 24, 11[C07H, C12Q, C40B]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.